All Stories

  1. The Messenger, Not the Message: Rethinking Eosinophils as Biomarkers for Biologic Therapy in COPD
  2. Ending the global neglect of pneumonia: from awareness to accountability
  3. Assessment of COPD Acute Exacerbations by the Baseline, Acuity, and Trigger (BAT) Model
  4. Chest Wall Deformity and Rib Fractures in Breast Cancer Patients Following Reconstruction with Tissue Expanders
  5. The role of early CPET follow-up after acute PE in predicting long-term outcomes
  6. Prediction of New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction: A Machine Learning Approach
  7. Secretory carcinoma of the breast: A case report
  8. Advanced Pulmonary Drug Delivery Systems: A Narrative Review
  9. Features of Lipid Disorders in Cardiovascular–Kidney–Metabolic Syndrome
  10. Clinical and Imaging Predictors of Bronchopulmonary Dysplasia in Premature Infants
  11. Impact of Sex on Clinical Profile and Depression in Patients with COPD
  12. Mortality of adults hospitalized with community-acquired pneumonia in a tertiary level pulmonary clinic
  13. Multimorbidity patterns in chronic obstructive pulmonary disease and their associations with disease severity
  14. Rethinking OSA Severity: The Modified Baveno Classification Identifies High-Risk Patients Missed by AHI
  15. The baseline, acuity, and trigger (BAT) model in assessment of exacerbations of COPD
  16. Correction: Gender disparities in heart failure diagnosis and management: under the radar
  17. Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  18. Global, regional, and national burden of exposure to chewing tobacco, 1990–2023: a systematic analysis of the Global Burden of Disease Study 2023
  19. Gender disparities in heart failure diagnosis and management: under the radar
  20. Prediction of New Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction Using Artificial Intelligence and Machine Learning Algorithms
  21. Tuberculosis worldwide: how far are we from ending it, with and without HIV?
  22. How type 2 diabetes and COPD affect each other: a review of mechanisms and patient management
  23. COPD Trial Evidence Comes from a Narrow Slice of the World: A Population Representativeness Analysis.
  24. Kounis Syndrome Features in Special Populations
  25. Impact of older age on prognosis in hypersensitivity pneumonitis: A systematic review and meta‑analysis
  26. COPD and kidney disease: not so far apart?
  27. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  28. A deep dive into atrial fibrillation in chronic obstructive pulmonary disease
  29. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  30. Ensuring patient safety: a closer look at glucocorticoid therapy in COPD and asthma
  31. COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives
  32. Clinical and immunological assessment of thyroid pathology in rheumatoid arthritis
  33. Pneumonia worldwide: who dies, from which germs, and where we are falling behind
  34. Patients with sickle cell disease and asthma have a higher risk for acute chest syndrome: A systematic review and meta‑analysis of observational studies
  35. Impact of urogenital and enterocolitic infections on the onset and evolution of ankylosing spondylitis and psoriatic arthritis
  36. Chronic obstructive pulmonary disease (COPD) and autoimmune diseases: unravelling complex interactions
  37. The Hidden Burden of COMISA: Clinical Implications and Treatment Challenges
  38. Burden of ophthalmologic disorders in obstructive sleep apnea
  39. Diagnostic and management controversies in ANCA-associated interstitial lung diseases
  40. Fungal allergy - features of molecular diagnosis
  41. Cardiopulmonary exercise testing in chronic obstructive pulmonary disease
  42. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  43. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  44. Diagnostic challenges in differentiating pulmonary sarcoidosis from tuberculosis: the role of QuantiFERON TB Gold in an endemic region
  45. Potential of doxofylline in the treatment of chronic obstructive airway diseases (Review)
  46. The impact of comorbidities on chronic obstructive pulmonary disease
  47. Tuberculosis in new cases: the impact of HIV status on clinical manifestations
  48. Comparative analysis of clinical characteristics of gout patients
  49. Chronic Obstructive Pulmonary Disease and Depression—The Vicious Mental Cycle
  50. Anti-reflux therapy and mortality in patients with idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a systematic review and meta-analysis
  51. Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders—Part II
  52. Diurnal variation in spirometry parameters of patients with chronic obstructive pulmonary disease: A systematic review and meta‑analysis
  53. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  54. Metabolic storm in psoriatic arthritis: a cardiovascular time bomb?
  55. Diagnostic tools in respiratory medicine (Review)
  56. COPD and Depression—The Vicious Mental Cycle
  57. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  58. Weltweite Perspektiven von Krankenhauspatienten zum Einsatz von künstlicher Intelligenz im Gesundheitswesen: Ergebnisse der COMFORT-Studie aus 74 Krankenhäusern in 43 Ländern
  59. Challenges of Pediatric Tuberculosis Under Current Conditions
  60. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  61. Global cross-sectional student survey on AI in medical, dental, and veterinary education and practice at 192 faculties
  62. Assessment of comorbidities in COPD patients by chest HRCT
  63. Endobronchial foreign bodies in pediatric work – history and clinical signs suggestive of diagnosis
  64. Sarcoidosis and cancer - a diagnostic dilema
  65. Multinational attitudes towards AI in healthcare and diagnostics among hospital patients
  66. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  67. Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity
  68. Particularities of comorbidities in nonalcoholic fatty liver disease according to gender groups
  69. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  70. Editorial: Treatment of comorbidities of asthma and its safety
  71. Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
  72. Hypersensitivity Pneumonitis: Challenges of a Complex Disease
  73. Medical students’ perceptions towards artificial intelligence in education and practice: A multinational, multicenter cross-sectional study
  74. Israel−Palestine Conflict: Risk of Sleep Disorders and Post-Traumatic Stress Disorders
  75. Promising treatment biomarkers in asthma
  76. Complications of tracheobronchial foreign body aspiration in children
  77. Phenotypes in adult patients with bronchiectasis: a cluster analysis
  78. The Burden of Comorbidities in Obstructive Sleep Apnea
  79. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
  80. Prevalence and Burden of Comorbidities in Obstructive Sleep Apnea Syndrome
  81. Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
  82. Updates in screening for tuberculosis. Review of guidelines
  83. Diagnostic challenges of a rare disease with an unusual presentation
  84. Peripheral neuropathy: A neglected cause of disability in COPD – A narrative review
  85. Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials
  86. COPD and Diabetes Mellitus: Down the Rabbit Hole
  87. Scientists Against War: A Plea to World Leaders for Better Governance
  88. COPD and comorbidities in the Republic of Moldova
  89. Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
  90. Asthma and obstructive sleep apnoea in adults and children – an up-to-date review
  91. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  92. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review
  93. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea
  94. Multidimensional indices in the assessment of chronic obstructive pulmonary disease
  95. Asthma-COPD Overlap: A more Simplistic Approach
  96. Chronic obstructive disease and comorbidities (literature review)
  97. Current Approaches to Asthma In 2021
  98. A rare case of intrathymic epidermoid cyst
  99. Asthma and stroke: a narrative review
  100. Adenoid hypertrophy can impact craniofacial growth and lead to obstructive sleep apnea in children
  101. Coenzyme Q10 suplement in chronic obstructive pulmonary disease
  102. Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
  103. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  104. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  105. Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
  106. Current Approaches to COPD in 2019
  107. “Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.”
  108. Spontaneous Pneumomediastinum – a Rare Asthma Complication
  109. Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
  110. Identification of clinical phenotypes using cluster analyses in COPD patients
  111. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
  112. A MULTILATERAL APPROACH TO COPD COMORBIDITIES
  113. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)
  114. COPD and Stroke
  115. Health-related quality of life in different phenotypes of COPD
  116. Assessment of health-related quality of life in different phenotypes of COPD
  117. Bode index in different phenotypes of COPD
  118. To sleep, or not to sleep?
  119. ACOS: current evidence and future research directions
  120. Phenotyping Before Starting Treatment in COPD?
  121. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  122. Exercise-Induced Pulmonary Edema in Athletes
  123. Editorial: "COPD: More than a Moving Target!"
  124. P51 Clinical effectiveness of procalcitonin based protocols to guide the administration of antibiotics in patients presenting with COPD exacerbations: systematic review and meta-analysis
  125. Prevalence and burden of comorbidities in COPD
  126. Meet Our Assistant Editor
  127. Overview of the translocation of rupestrian ferruginous fields of Capão Xavier mine to the Serra do Rola Moça State Park, Minas Gerais – Brazil
  128. Editorial: Continuous Positive Airway Pressure: Life-Saving Technology
  129. Health-Related Quality of Life in Patients with COPD
  130. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation
  131. Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
  132. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
  133. Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
  134. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
  135. Management of Stable COPD: An Update
  136. Breast cancer local recurrence under the form of inflammatory carcinoma, treated with concurrent radiation and chemotherapy, a case report
  137. Defining COPD
  138. Imaging for diagnosis and management of tuberculosis